Document Detail

Cardioprotection: chances and challenges of its translation to the clinic.
MedLine Citation:
PMID:  23095318     Owner:  NLM     Status:  Publisher    
Myocardial infarct size is a major determinant of prognosis. Ischaemic preconditioning with brief coronary occlusion and reperfusion before a sustained period of coronary occlusion with reperfusion delays infarct development. Ischaemic postconditioning uses repetitive brief coronary occlusion during early reperfusion of myocardial infarction and reduces infarct size. Remote ischaemic preconditioning uses brief ischaemia and reperfusion of a distant organ to protect the myocardium. These conditioning protocols recruit a complex signal cascade of sarcolemmal receptor activation, intracellular enzyme activation, and ultimately mitochondrial stabilisation and inhibition of death signalling. Conditioning protocols have been successfully used in patients undergoing elective coronary revascularisation and reperfusion after acute myocardial infarction. Pharmacological recruitment of cardioprotective signalling has also been used to reduce infarct size, but so far without prognostic benefit. Outcomes of cardioprotection are affected by age, sex, comorbidities, and drugs, but also by technical issues related to determination of infarct size and revascularisation procedure.
Gerd Heusch
Related Documents :
3882278 - Comparison of enzyme immunoassay and immunoprecipitation for creatine kinase mb in diag...
8981658 - Implications of automated creatine kinase (ck)-mm1,2,3/ck-mb1,2 isoform analysis as an ...
17010458 - Cardiac troponin i release in non-ischemic reversible myocardial injury from parvovirus...
11796438 - Use of biochemical markers of infarction for diagnosing perioperative myocardial infarc...
23891308 - Left atrial myxoma presenting as paroxysmal supraventricular tachycardia.
8435248 - Total atrial paralysis after permanent dual chamber cardiac pacing.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-19
Journal Detail:
Title:  Lancet     Volume:  -     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anisakis simplex Hypersensitivity Is Associated with Chronic Urticaria in Endemic Areas.
Next Document:  The nature of progress in nanopatterning.